|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113.81 USD | +0.40% |
|
+4.93% | +15.23% |
| 06-30 | FDA clears Orca's blood cancer therapy to reduce stem cell transplant complications | RE |
| 06-29 | Incyte Corporation(NasdaqGS:INCY) dropped from Russell Midcap Growth Benchmark | CI |
| Market Cap | 22.74B 19.96B 18.38B 17.12B 32.29B 2,162B 32.95B 221B 85.63B 1,061B 85.37B 83.53B 3,693B | P/E 2026 * |
16.5x | P/E 2027 * | 14.3x |
|---|---|---|---|---|---|
| Enterprise Value | 17.72B 15.56B 14.32B 13.34B 25.16B 1,685B 25.68B 172B 66.73B 827B 66.53B 65.09B 2,878B | EV / Sales 2026 * |
3.14x | EV / Sales 2027 * | 2.55x |
| Free-Float |
98.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Incyte Corporation
| 1 day | +0.40% | ||
| 1 week | +4.93% | ||
| Current month | +0.40% | ||
| 1 month | +19.06% | ||
| 3 months | +20.69% | ||
| 6 months | +15.23% | ||
| Current year | +15.23% |
| 1 week | 109.48 |  | 116 |
| 1 month | 92.66 | | 116 |
| Current year | 89.25 | | 116 |
| 1 year | 66.85 | | 116 |
| 3 years | 50.27 | | 116 |
| 5 years | 50.27 | | 116 |
| 10 years | 50.27 | | 153.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Meury
CEO | Chief Executive Officer | 58 | 25/06/2025 |
Suketu Upadhyay
DFI | Director of Finance/CFO | 57 | 03/05/2026 |
Pablo Cagnoni
PSD | President | 62 | 04/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Julian Baker
CHM | Chairman | 59 | 25/06/2025 |
| Director/Board Member | 72 | 19/01/2015 | |
Paul Clancy
BRD | Director/Board Member | 64 | 19/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-07 | Free | Director | 7,753 | 0.0039% | ||
| 06-07 | Other | Director | 0 | 0% | ||
| 06-07 | Free | Director | 7,753 | 0.0039% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.40% | +4.93% | +65.59% | +82.83% | 22.74B | |
| +0.19% | +0.21% | +16.79% | -13.06% | 63.56B | |
| +1.09% | +1.56% | +56.33% | +227.72% | 55.92B | |
| +0.36% | +39.60% | +39.60% | +39.60% | 41.68B | |
| -0.52% | +0.08% | -50.89% | -57.38% | 39.12B | |
| -2.93% | +5.09% | +61.25% | -26.37% | 30.97B | |
| +3.53% | +19.99% | +152.70% | -40.33% | 28.77B | |
| +7.22% | +12.16% | +7.63% | +184.50% | 17.64B | |
| +0.45% | +0.26% | +65.10% | +126.32% | 16.66B | |
| +0.05% | +7.44% | +74.19% | +333.26% | 14.6B | |
| Average | +0.98% | +4.95% | +48.83% | +85.71% | 33.16B | |
| Weighted average by Cap. | +0.67% | +3.98% | +42.09% | +64.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.65B 4.96B 4.56B 4.25B 8.02B 537B 8.18B 54.88B 21.26B 263B 21.2B 20.74B 917B | 6.22B 5.46B 5.02B 4.68B 8.83B 591B 9.01B 60.43B 23.42B 290B 23.34B 22.84B 1,010B |
| Net income | 1.44B 1.26B 1.16B 1.08B 2.04B 137B 2.08B 13.97B 5.41B 67.07B 5.4B 5.28B 233B | 1.67B 1.47B 1.35B 1.26B 2.38B 159B 2.43B 16.27B 6.3B 78.11B 6.28B 6.15B 272B |
| Net Debt | -5.02B -4.41B -4.06B -3.78B -7.13B -477B -7.27B -48.78B -18.9B -234B -18.84B -18.44B -815B | -6.87B -6.04B -5.56B -5.18B -9.76B -654B -9.96B -66.82B -25.89B -321B -25.81B -25.25B -1,116B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/07/26 | US$113.81 | +0.40% | 1,711,033 |
| 30/06/26 | US$113.36 | -1.13% | 1,830,643 |
| 29/06/26 | US$114.66 | +0.80% | 1,532,380 |
| 26/06/26 | US$113.75 | +5.78% | 3,795,266 |
| 25/06/26 | US$107.53 | -0.86% | 1,832,481 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INCY Stock
Select your edition
All financial news and data tailored to specific country editions
